Search
PATHSiTE LOG IN
PATHSiTE® is our web-based tool with applications to help you view and manage your cases.
Learn more Log In
 

Join us to hear specialists, gain insights, and learn about innovations in the industry in your own community.
EGFR Mutational Analysis
Learn more

The Role of KRAS Mutation Testing in the Management of Patients With Metastatic Colorectal Cancer — Full Test Article

New WHO Reclassification of Myeloproliferative Disorders
Learn more
 
DecipherDX_Insight-Logo_Breast-Cancer.gif

Clarient's new breast cancer test helps physicians identify the probability of a patient's cancer returning, and assess the need for chemotherapy.
In The News
Clarient CEO Ron Andrews to Present at the UBS 20th Annual Global Healthcare Services Conference in New York City  Read more...